AiM is the market access and reimbursement specialist for Germany, Austria and Switzerland. Founded in 2007 and based in Lörrach, Germany, AiM has already implemented over 800 projects to date.

Medical device and digital health product inventors receive comprehensive support, from clinical trial planning to product lifecycle management. AiM assists with:

Pre-launch market analysis (evaluation of market entry options, identification of market sectors)

Reimbursement strategies for digital health apps
-Market access and reimbursement
-Support for inclusion in the DiGA directory
-Assessment of alternative reimbursement pathways outside the DVG (Digitales-Versorgungs-Gesetz)

Health Technology Assessment (HTA) simulation and preparation for medical devices:
- Evaluation of study design and protocol
- Dentification of HTA evaluation criteria for the respective indication and procedure
- Gap analysis
- Recommendations on HTA requirements)
- Accompaniment of G-BA method evaluation
- Compilation and accompaniment of G-BA applications for wound dressings and drug-alike medical devices
- Clinical trial planning (advice on study design and statistics)
- Reimbursement options (reimbursement and pricing, parallel reimbursement pathways, reimbursement and market entry schedule, risk assessment with regard to the HTA process (G-BA method assessment))
- NUB applications (Neue Untersuchungs- und Behandlungsmethode - new examination and treatment methods)
- ZE applications (Zusatzentgelt - supplementary charge)
- DRG applications
- OPS code applications (operations and procedure codes)

For more information, please contact AiM:

Marie-Curie-Straße 8
D-79539 Lörrach
P: +49 7621 705 105 0

Digital Health Apps in Germany

Market Access and Reimbursement for Digital Health Apps in Germany
New, expanded edition with additional information on digital nursing care apps.
Learn more with our 36 paged guide.

If you would like to order the guide, please write an email to Ms. Agata Daroszewska.

Digital Health Apps in Germany